March 2025

Upcoming Events and Opportunities

Upcoming WP9 Events: Pioneering Innovation in Cancer Screening

upcoming events

WP9 Upcoming Meetings Overview (Chronological Order)

📍 Task 9.5

📅 January–May 2025:

Series of consensus meetings
(Ongoing, no specific dates)

📍 Task 9.6

📅 Late March 2025:

Next core group meeting
(Ongoing meetings, next one in late March 2025)

📍 Task 9.7 – First Session

📅 March 5–7, 2025:

Location: National Korányi Institute for Pulmonology, Budapest, Hungary

📍 Task 9.2

📅 March 12, 2025:

Meeting to finalize the Conceptual Framework

📅 Mid-April 2025:

Meeting to finalize the Conceptual Framework

📍 Task 9.3

📅 April 1, 2025:

Kick-off meeting with a RISCC webinar presentation

📍 Task 9.7 – Second Session

📅 April 9–11, 2025:

Location: Institute for the Study and Prevention of Cancer, Florence, Italy

📍 Task 9.2 & Task 9.7

📅 May 12–14, 2025:

Turin Consortium Meeting – dedicated session on Task 9.2 and 9.7

📍 Task 9.7 – Third Session

📅 May 21–23, 2025:

Location: National Korányi Institute for Pulmonology, Budapest, Hungary

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical

 

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

tiktok

FaceBook

X

Instagram

YouTube

LinkedIn

email

EUCanScreenLogo t

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook

Twitter

Instagram

YouTube

LinkedIn

Logo EU

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Print Friendly, PDF & Email
Μετάβαση στο περιεχόμενο